Verition Fund Management
MDCX

Verition Fund Management’s Medicus Pharma MDCX Stock Holding History

Verition Fund Management’s Portfolio MDCX Stock Details MDCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,385
Closed -$160K – 4045
2025
Q2 		$160K Buy
+53,385
New +$213K ﹤0.01% 3413

Other funds holding MDCX

ICP
Interchange Capital Partners Pittsburgh, Pennsylvania $532M AUM 26.57% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return
BAM
Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BWM
Base Wealth Management Lakewood Ranch, Florida $215M AUM 19.13% 1-Year Est. Return

Verition Fund Management's MDCX Position: Q3 2025 in Review

Verition Fund Management sold out of Medicus Pharma (MDCX) in Q3 2025, closing a stake of 53,385 shares — an estimated $160K sold.

Verition Fund Management first reported a position in MDCX in Q2 2025 and held it in 1 quarter. The position peaked at $160K in Q2 2025. 20 funds tracked by Wall St. Rank hold MDCX as of Q3 2025.

  • Verition Fund Management reported no remaining Medicus Pharma position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 53,385 Medicus Pharma shares in Q3 2025, an estimated $160K.
  • Verition Fund Management first reported a position in Medicus Pharma in Q2 2025 and held it in 1 quarter.
  • Verition Fund Management's Medicus Pharma position peaked at $160K in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Medicus Pharma as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.